Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04244552
Title First-in-Human Dose Escalation Trial of ATRC-101 in Adults With Advanced Solid Malignancies
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Atreca, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.